Owlet Inc
Owlet Inc is a provider of advanced medical equipment and technology, specializing in wearable health monitoring devices for infants and children.
Business. Owlet Inc (OWLT.K) is a healthcare company operating in the Advanced Medical Equipment & Technology industry. The firm is headquartered in the United States and is primarily listed on the New York Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Analyst recommendations
5 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Owlet Inc (OWLT.K) is a healthcare company operating in the Advanced Medical Equipment & Technology industry. The firm is headquartered in the United States and is primarily listed on the New York Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Owlet Inc operates with a negative equity position of -$20.83 million and a total debt of $11.85 million, indicating a leveraged capital structure. The company's liquidity position is constrained, with $15.36 million in cash and equivalents, but a current ratio of 1.01 suggests limited short-term liquidity buffer. The negative return on equity of 5.51% and a negative return on assets of -2.5% highlight the company's underperformance in generating returns from its equity and asset base.
The company's operating income of -$2.24 million and net income of -$1.15 million indicate ongoing operational losses. These figures are below the industry median for profitability metrics, suggesting that Owlet Inc is not performing as well as its peers in terms of generating profit. The gross profit margin of 49.5% is relatively high, but this is offset by significant operating expenses that erode profitability.
Owlet Inc's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to market-specific risks and limits its ability to offset losses in one area with gains in another. The company's revenue of $20.70 million is modest compared to industry leaders, and there is no indication of significant geographic expansion.
The company's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year. The negative operating cash flow of -$6.72 million and free cash flow of -$2.60 million indicate that the company is not generating sufficient cash to fund operations or growth initiatives. The capital expenditure of -$74,000 suggests minimal investment in long-term assets, which may limit future growth potential.
The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. However, the company's negative equity and high debt-to-equity ratio of -0.57 suggest potential financial instability. The dilution potential is low, but the company's negative net income and operating cash flow could necessitate future equity raises, which may dilute existing shareholders.
Recent events include analyst estimates indicating a strong buy recommendation with a mean price target of $14.25 and a median price target of $14.50. These estimates suggest that analysts have a positive outlook on the company's future performance, despite its current financial challenges.
- Owlet Inc is operating at a loss with negative equity and high debt, indicating financial distress.
- The company's profitability metrics are below industry medians, suggesting underperformance relative to peers.
- Owlet Inc's revenue is concentrated in a single segment with no geographic diversification, increasing business risk.
- Analysts have a positive outlook on the company, with a mean price target significantly higher than the current market price.
- The company's liquidity position is weak, with limited cash reserves and a current ratio near 1.0.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue $22.5M; Net margin -14.9%.
- ▍Revenue $22.5M
- ▍Net margin -14.9%
Revenue $26.6M; Operating income -$4.9M.
- ▍Revenue $26.6M
- ▍Operating income -$4.9M
- ▍Net margin -34.6%
Revenue $20.7M; Operating income -$2.2M.
- ▍Revenue $20.7M
- ▍Operating income -$2.2M
- ▍Net margin -5.5%
Revenue $54.0M, −21,9% YoY; Operating income +66,2% YoY.
- ▍Revenue $54.0M, −21,9% YoY
- ▍Operating income +66,2% YoY
- ▍Net income +58,5% YoY
- ▍Free cash flow +53,8% YoY
- ▍Net margin -60.9%
Revenue $69.2M, −8,8% YoY; Operating income −57,6% YoY.
- ▍Revenue $69.2M, −8,8% YoY
- ▍Operating income −57,6% YoY
- ▍Net income −10,6% YoY
- ▍Free cash flow −9,5% YoY
- ▍Net margin -114.6%
Revenue $75.8M; Operating income -$53.7M.
- ▍Revenue $75.8M
- ▍Operating income -$53.7M
- ▍Net margin -94.5%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,25 |
| Revenue | —no estimate | —no estimate | 127,3M USD |
| Operating income | —no estimate | —no estimate | -7,5M USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Warrant (Right to Buy) → Common StockDisposed 131 195 @ $4,44disposition · 2025-10-10
- Director · Warrant (Right to Buy) → Common StockDisposed 131 195 @ $4,44disposition · 2025-10-10
- Director · Warrant (Right to Buy) → Common StockDisposed 48 621 @ $4,09disposition · 2025-10-10
- 10% owner · Warrant (Right to Buy) → Common StockDisposed 712 915conversion · 2025-10-10
- 10% owner · Warrant (Right to Buy) → Common StockDisposed 444 601conversion · 2025-10-10
- Director, 10% owner, Director by Deputization · Series A Warrants (Right to Purchase Shares of Common Stock) → Common StockDisposed 5 300 291disposition · 2025-10-10
- Director, 10% owner, Director by Deputization · Series B Warrants (Right to Purchase Shares of Common Stock) → Common StockDisposed 1 166 935disposition · 2025-10-10
- Director, 10% owner · Series B Warrants (Right to Purchase Shares of Common Stock) → Class A Common StockDisposed 1 166 935disposition · 2025-10-10
- Director, 10% owner · Series A Warrants (Right to Purchase Shares of Common Stock) → Class A Common StockDisposed 5 300 291disposition · 2025-10-10
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Owlet Inc Market data — financials · 2026-05-28
- Owlet Inc Market data — analyst estimates · 2026-05-28
- Owlet Inc Market data — ESG · 2026-05-28
Ownership & reference
Top holders
- Institutional Investor · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2025-12-310,00 %$14M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2024-06-300,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
- President & CEO · Common StockOther 850 000 · 2026-04-28
- Chief Financial Officer · Common StockOther 141 @ $5,66$798 · 2026-04-15
- Chief Financial Officer · Common StockOther 32 032 @ $4,92$158K · 2026-04-03
- Chief Financial Officer · Common StockOther 9 242 @ $5,10$47K · 2026-04-03
- Chief Financial Officer · Common StockOther 19 191 @ $5,11$98K · 2026-03-25
- Chief Financial Officer · Common StockSold 6 892 @ $11,50$79K · 2026-02-27
- Former President & CEO · Common StockSold 12 676 @ $11,50$146K · 2026-02-26
- Former President & CEO · Common StockOther 41 666 · 2026-02-26
- Chief Financial Officer · Common StockOther 20 833 · 2026-02-25
- Former President & CEO · Common StockSold 3 540 @ $10,65$38K · 2026-02-17
- Chief Financial Officer · Common StockSold 183 @ $13,33$2K · 2026-01-20
- President and CEO · Common StockSold 2 311 @ $13,33$31K · 2026-01-20
- Former President & CEO · Common StockSold 3 423 @ $10,49$36K · 2025-11-17
- Director · Common StockOther 18 996 · 2025-10-16
- Former President & CEO · Common StockSold 1 851 @ $8,75$16K · 2025-10-16
- Chief Financial Officer · Common StockSold 149 @ $8,75$1K · 2025-10-16
- Director · Common StockOther 18 996 · 2025-10-16
- Director · Common StockOther 18 996 · 2025-10-16
- Director, 10% owner, Director by Deputization · Common StockOther 3 898 906 · 2025-10-10
- Director · Common StockOther 80 235 · 2025-10-10
- Director · Common StockOther 107 626 · 2025-10-10
- 10% owner · Common StockOther 686 469 · 2025-10-10
- Director, 10% owner · Common StockOther 3 898 906 · 2025-10-10
- President & CEO · Common StockSold 49 056 @ $8,46$415K · 2025-10-03
- Former President & CEO · Common StockOther 60 024 · 2025-09-30
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -24.4%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 72.9%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 164.0%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 35.4%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 43.6%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 59.1%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 3.7%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -216.5%Derived (calculated)
- Gross margin (FY 2025-12-31): 50.6%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -43.1%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 36.2%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -47.1%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 34.7%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 75.2%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 680.0%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 2.64xDerived (calculated)
- Current ratio (FY 2025-12-31): 1.85xDerived (calculated)
- Return on assets (FY 2025-12-31): -46.3%Derived (calculated)
- Return on equity (FY 2025-12-31): -208.4%Derived (calculated)
- Net margin (FY 2025-12-31): -37.5%Derived (calculated)
- Shares outstanding (annual): 26.95MSEC XBRL filing
- Operating cash flow (annual): USD -10.79MSEC XBRL filing
- Current assets (annual): USD 81.92MSEC XBRL filing
- Total assets (annual): USD 85.63MSEC XBRL filing